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BASIC SCIENCE ARTICLE OPEN
Hypothermia is not therapeutic in a neonatal piglet model of
inflammation-sensitized hypoxia–ischemia
Kathryn A. Martinello1,2, Christopher Meehan1, Adnan Avdic-Belltheus1, Ingran Lingam1, Tatenda Mutshiya1, Qin Yang1,
Mustafa Ali Akin3, David Price4, Magdalena Sokolska4, Alan Bainbridge4, Mariya Hristova1, Ilias Tachtsidis5, Cally J. Tann6,
Donald Peebles1, Henrik Hagberg7,8, Tim G. A. M. Wolfs9, Nigel Klein10, Boris W. Kramer9, Bobbi Fleiss11,12, Pierre Gressens12,
Xavier Golay13 and Nicola J. Robertson1,14
BACKGROUND: Perinatal inflammation combined with hypoxia–ischemia (HI) exacerbates injury in the developing brain.
Therapeutic hypothermia (HT) is standard care for neonatal encephalopathy; however, its benefit in inflammation-sensitized HI
(IS-HI) is unknown.
METHODS: Twelve newborn piglets received a 2 µg/kg bolus and 1 µg/kg/h infusion over 52 h of Escherichia coli lipopolysaccharide
(LPS). HI was induced 4 h after LPS bolus. After HI, piglets were randomized to HT (33.5 °C 1–25 h after HI, n= 6) or normothermia
(NT, n= 6). Amplitude-integrated electroencephalogram (aEEG) was recorded and magnetic resonance spectroscopy (MRS) was
acquired at 24 and 48 h. At 48 h, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive brain cell death,
microglial activation/proliferation, astrogliosis, and cleaved caspase-3 (CC3) were quantified. Hematology and plasma cytokines
were serially measured.
RESULTS: Two HT piglets died. aEEG recovery, thalamic and white matter MRS lactate/N-acetylaspartate, and TUNEL-positive cell
death were similar between groups. HT increased microglial activation in the caudate, but had no other effect on glial activation/
proliferation. HT reduced CC3 overall. HT suppressed platelet count and attenuated leukocytosis. Cytokine profile was
unchanged by HT.
CONCLUSIONS: We did not observe protection with HT in this piglet IS-HI model based on aEEG, MRS, and immunohistochemistry.
Immunosuppressive effects of HT and countering neuroinflammation by LPS may contribute to the observed lack of HT efficacy.
Other immunomodulatory strategies may be more effective in IS-HI.
Pediatric Research _#####################_ ; https://doi.org/10.1038/s41390-021-01584-6
IMPACT:
● Acute infection/inflammation is known to exacerbate perinatal brain injury and can worsen the outcomes in neonatal
encephalopathy.
● Therapeutic HT is the current standard of care for all infants with NE, but the benefit in infants with coinfection/inflammation is
unknown.
● In a piglet model of inflammation (LPS)-sensitized HI, we observed no evidence of neuroprotection with cooling for 24 h, based
on our primary outcome measures: aEEG, MRS Lac/NAA, and histological brain cell death.
● Additional neuroprotective agents, with beneficial immunomodulatory effects, require exploration in IS-HI models.
INTRODUCTION
Therapeutic hypothermia (HT) is standard care for neonates with
intrapartum-related neonatal encephalopathy (NE) under inten-
sive care settings. Cooling to 33.5 °C for 72 h improves survival free
from disability in the short and long term.1,2 However, cooling is
ineffective in preventing disabilities in a proportion of infants
(number needed to treat, 7 (95% confidence interval (CI) 5–10) for
reduction in death or neurodisability at 18 months).1 It is clear
that, while disability from cerebral palsy (CP) in NE survivors
reduces from 35%1 to as low as 16%3 with HT, some level of
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intellectual impairment may remain even in the absence of CP.4
Attenuated efficacy of HT may be due to severity of illness, timing
of insult in relation to initiation of HT, or sensitization with
coexisting infection/inflammation.
In preclinical laboratory studies demonstrating HT efficacy, NE
is typically modeled with hypoxic–ischemic (HI) brain injury.
However, in the clinical setting, the etiology of NE is multi-
factorial, with contributions from antenatal and placental
pathology,5 genetic susceptibility,6 and perinatal infection/
inflammation7 in addition to sentinel HI events.8 Preclinical7,9,10
and clinical11 studies suggest that acute infection/inflammation
sensitizes the brain to subsequent HI, lowering the injury
threshold and worsening outcome.7,12 Mortality amongst infants
with combined NE and infection is increased compared with NE
alone.13 We have recently demonstrated an increase in mortality
and brain cell death in Escherichia coli (E. coli) LPS-sensitized
hypoxic brain injury in the piglet model, compared with either E.
coli LPS or hypoxia alone.10 These data concur with studies of
small animal models of inflammation-sensitized HI (IS-HI).9,14,15
Given the increase in the severity of brain injury and mortality,
effective therapeutic interventions are urgently needed for
infants with IS-HI.
The benefit and safety of cooling infants with IS-HI are
unclear. HT induces alterations in leukocyte number, microglial
cell16 activation,17 cytokine/chemokine profiles,18 and hemody-
namics;19 it is plausible that immunomodulatory effects of HT
may not be beneficial in the context of inflammation sensitiza-
tion. In a small prospective study of placental histology
relative to magnetic resonance imaging (MRI) outcomes, HT
was less protective for infants with NE where placental histology
showed chorioamnionitis.20 In low-resource settings, where
rates of IS-HI are high, HT may be less effective, and potentially
harmful.21,22 In addition, HT has been shown to be deleterious
in the presence of meningitis23 and sepsis24 in adult clinical
studies. These observations emphasize the critical need for
preclinical animal models that assess the safety and efficacy of
HT and other neuroprotective agents in IS-HI. Rodent IS-HI
models suggest variable, pathogen-dependent, efficacy of
HT.14,15,25 This has not previously been examined in a large
animal model.
The aim of this study was to assess the safety and efficacy of
HT in an E. coli LPS-sensitized HI piglet model. The piglet model
has strong similarities to newborn infants with NE in terms of
the evolution and pattern of injury after HI and neuropathol-
ogy.26,27 We hypothesized that HT would not provide
neuroprotection in IS-HI based on our primary outcome
measures: (i) amplitude-integrated electroencephalogram
(aEEG) background activity recovery over 48 h; (ii) proton (1H)
magnetic resonance spectroscopy (MRS) lactate/N-acetylaspar-
tate ratio (Lac/NAA) at 48 h in the subcortical white matter and
thalamus; and (iii) terminal deoxynucleotidyl transferase dUTP
nick-end labeling (TUNEL) immunolabelling of histological cell
death over the whole-brain and eight brain regions at 48 h
after HI.
METHODS
This study was conducted in accordance with the UK Home Office
Guidelines [Animals (Scientific procedures) Act, 1986] and
complies with ARRIVE guidelines. The Ethics Committee of
University College London approved the study.
Sample size calculation
Using previous data from our piglet study of LPS plus hypoxia
(geometric least-squares mean standard deviation of 17), we
estimated that six piglets per intervention group were required to
detect a difference in TUNEL-positive cells of >30 cells/mm2, using
a significance threshold of 5 and 80% power.
Animal experiments and surgical preparation
Male large white piglets aged ≤36 h were sedated with
intramuscular midazolam (150 μg) and anesthetized with 2–3%
(v/v) isoflurane. Piglets underwent tracheostomy and mechanical
ventilation (SLE 2000 Infant Ventilator, Surrey, UK). The bilateral
common carotid arteries were surgically isolated and encircled by
inflatable occluders (OC2A, In Vivo Metric). A 2-French central
venous catheter (Vygon, Swindon, UK) was inserted into the
axillary or brachial vein for later infusion of LPS. Umbilical
catheters were sited; a 4-French double-lumen umbilical venous
catheter (Vygon) was used for maintenance fluids (10% dextrose,
60ml/kg/day, reduced to 40ml/kg/day post HI), fentanyl (3 μg/kg/
h), and antibiotics (benzylpenicillin 50mg/kg every 12 h and
gentamicin 2.5 mg/kg every 24 h); and a 2.5-French umbilical
arterial catheter (Vygon) for intermittent blood sampling (Abbot
Laboratories, UK) and continuous monitoring of heart rate and
mean arterial blood pressure (MABP). Arterial catheters were
maintained with 0.3 ml/h heparinized saline (1 IU/ml in 0.9% saline
solution). Core (rectal) temperature was maintained in the
normothermic range during surgery using a radiant warmer. The
duration of surgery was 1–2 h.
Following surgery, piglets were positioned prone within a
bespoke MRI-compatible transport incubator. Intensive care
support and physiological monitoring (SA Instruments, London,
UK) was continued throughout the study. Ventilation was adjusted
to maintain partial pressure of oxygen (PaO2) and carbon dioxide
(PaCO2) at 8–13 and 4.5–6.5 kPa, respectively. MABP was
supported with crystalloid (0.9% saline, Baxter, 10 ml/kg bolus)
and inotropes (dopamine 5–25 μg/kg/min, dobutamine 5–20 μg/
kg/min, noradrenaline 0.1–1 μg/kg/min, adrenaline 0.1–1 μg/kg/
min) to target MABP >35mmHg. Anesthesia was maintained
throughout with fentanyl (3 μg/kg/h infusion) and isoflurane
(2–3% (v/v)). Hyperkalemia (potassium > 7.0 mmol/l) was treated
with 4 μg/kg intravenous salbutamol over 10 min.
EEG acquisition
Multichannel six-lead EEG (Nicolet, CareFusion, Madison, WI) was
commenced immediately post surgery and maintained through-
out the study. aEEG recordings were retrospectively scored hourly
using the pattern classification.28 Flat trace was assigned a score of
0; continuous low voltage 1; burst suppression 2; discontinuous
normal voltage 3; and continuous normal voltage 4. Scores were
averaged every 6 h. Electrographic seizures were treated with
phenobarbitone, initially 20 mg/kg, followed by 10mg/kg doses
for subsequent seizures, up to a maximum 40mg/kg.
Broadband near-infrared spectroscopy
A broadband near-infrared spectroscopy (bNIRS) system (Mini-
CYRIL, Cytochrome Research Instrument and Application System,
UCL, UK) was used to measure the concentration of oxidized
cytochrome c oxidase (oxCCO).
LPS administration
Baseline physiological, bNIRS, and EEG data were captured prior to
administration of LPS. All piglets received a bolus of 2 μg/kg LPS
(E. coli-derived, Sigma LPS O55:B5, St. Louis, MO), followed by a
continuous infusion of 1 μg/kg/h LPS for the duration of the
experiment (total 52 h LPS).
Transient HI
Four hours after the LPS bolus, the carotid occluders were inflated
and the fraction of inspired oxygen (FiO2) was reduced to induce
transient HI. FiO2 was decreased sequentially to 6% over the first 3
min and maintained. The insult was titrated using continuous
MABP, EEG, and bNIR monitoring, and arterial blood gas was
measured at 5-min intervals. Target insult parameters included
MABP between 26 and 30mmHg, a 3-fold reduction in oxCCO
from baseline, a sustained isoelectric EEG, and metabolic acidosis
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(pH < 7.3, lactate > 10). FiO2 was liberalized in the event of MABP
and oxCCO values beyond the target range. The duration of insult
was anticipated to be 20min. At the end of the insult, occluders
were deflated, FiO2 normalized to 21%, and the animal
resuscitated as necessary.
Experimental groups: temperature management
Following insult, piglets were randomized, using a computer-
generated randomization sequence and opaque sequentially
numbered envelopes, to two groups: (i) LPS, HI, and normother-
mia (NT) and (ii) LPS, HI, and HT (Fig. 1). NT piglets had
core temperature maintained in the normothermic range
(38.0–39.0 °C) throughout the study. HT piglets were actively
cooled to 33.5 °C from 1 to 25 h post insult, and then rewarmed
over 10 h at an incremental rate of 0.5 °C/h.17 HT piglets were
subsequently maintained in the normothermic range until the
end of the study. Temperature was maintained within target
ranges using a water mattress (Tecotherm TSmed200, Inspira-
tion Healthcare, Crawley, UK) manually adjusted according to
continuous rectal temperature. The mattress was wrapped
around the trunk and limbs.
Magnetic resonance spectroscopy
MRS was acquired on a Philips Achiever 3 T (Philips Healthcare,
Best, The Netherlands) scanner at 24 and 48 h after HI. 1H
magnetic resonance spectra were acquired using a Philips 32-
channel head coil. Chemical shift imaging (CSI) based on a two-
dimensional point-resolved spectroscopy excitation used an 8 × 8
matrix with a voxel size of 7.5 × 7.5 mm2 and slab thickness of 10
mm. The repetition time was 2 s and the echo time was 288 ms. 1H
CSI data was processed using spectroscopy analysis software,
TARQUIN,29 yielding signal amplitudes for NAA and lactate. Two
regions were selected for the final analysis: a single voxel over the
dorsal right subcortical white matter at the centrum semi-ovale
level and the sum of two voxels over the lateral thalami.
Hematology and cytokine analysis
Arterial blood was collected at baseline, 4 h after LPS bolus, at the
end of HI, and at 3, 12, 24, and 48 h post HI. Cerebrospinal fluid
(CSF) was obtained by a lumbar puncture at baseline and at 48 h.
Hematology samples were stored at 4 °C for a maximum of 72 h
prior to complete blood film examination (Royal Veterinary
College Diagnostic Laboratory, Hawkshead Campus, UK). Hemo-
globin (Hb), total white cell (WBC), neutrophil, lymphocyte,
monocyte, and platelet count were analyzed. Serum and CSF
samples were frozen (−20 °C) for later protein analysis. Multiplex
porcine enzyme-linked immunosorbent assay (ELISA) was under-
taken to quantify interleukin-1β (IL-1β), IL-6, IL-8, and tumor
necrosis factor-α (TNFα) (Q-Plex Porcine Cytokine—High sensitivity
(4-Plex), ref.: 119149PC, Tebu-Bio, France), while a porcine ELISA
was utilized for IL-10 (Porcine IL-10 ELISA Kit (Cloud-Clone Corp.,
ref. SEA056Po), Tebu-Bio, France).
Brain histology
Forty-eight hours after HI, piglets were euthanized and
histological brain specimens were obtained and prepared as
previously described.10 Cell death was quantified by nuclear
DNA fragmentation using histochemistry with TUNEL. Glial
activation was quantified using the presence of astrocyte glial
fibrillary acidic protein (GFAP) and microglial ionized calcium-
binding adaptor molecule 1 (IBA1) immunoreactivity. Cleaved
caspase-3 (CC3) immunoreactivity was quantified. Histological
analysis was performed by investigators blind to the treatment
group. Eight brain regions were assessed (cingulate cortex,
sensorimotor cortex, hippocampus, periventricular white matter,
internal capsule, caudate nucleus, putamen, and thalamus). For
each region, TUNEL-positive nuclei were counted in six fields
(three per section, at ×40 magnification, with an area of 0.066
mm2) and the average converted into counts per mm2. IBA1-
positive cell body count was similarly performed. In addition,
IBA1 ramification index was calculated in six fields per region, at
×40 magnification, using a 0.049 mm × 0.049 mm square grid.
The microglial ramification index was calculated as (B2/C), where
C is the number of cell bodies within the grid, and B is the
number of branches crossing the three horizontal and three
vertical gridlines. CC3 immunoreactive cells were counted in
four fields per region (at ×20 magnification with an area of
0.164 mm2) and the average converted into counts per mm2. To
quantify the GFAP immunoreactivity optical luminosity values
were calculated by deducting mean brightness values of the
tissue (four fields per region at ×20 magnification) from the
mean brightness of the blank slide.
LPS bolus (2 µg/kg) and infusion (1 µg/kg/h)
Normothermia (NT)
Hypothermia (HT)
Cool 33.5 °C 1–25 h


























































Fig. 1 Study timeline. Following baseline recordings and surgery, piglets received a 2 µg/kg LPS bolus, followed by 1 µg/kg/h LPS infusion
continued for 52 h. After 4 h of infusion, piglets underwent a transient hypoxic–ischemic (HI) insult. Animals were subsequently randomized to
(i) normothermia (NT, core 38.0–39.0 °C throughout) or (ii) hypothermia (HT, 33.5 °C from 1 to 25 h post HI, then rewarmed at 0.5 °C/h). Blood
samples were collected at baseline, 4 h after bolus, end HI (time 0), and at 3, 12, 24, and 48 h after HI. EEG was continuously acquired,
excluding during MRS at 24 and 48 h. Piglets were maintained under meticulous intensive care for 48 h following HI, prior to euthanasia and
histological specimen collection.
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Non-normally distributed data were log-transformed prior to
analysis. Using SAS JMP® Pro v14.0.0, analysis of variance models
were fitted to give estimates of expected treatment group mean
values and difference between means. For TUNEL and histology
measurements, the effects of treatment, region, and the interac-
tion between them were fitted to the mean result for each subject
averaged across replicate measurements within each region. For
EEG, MRS, cytokines, and hematology, a model with terms for
treatment, time interval (as a factor) and the interaction between
them, and a random subject effect to take into account the
repeated-measures structure was fitted to the results for each
subject averaged across each time interval. Using the model, a
comparison to baseline was calculated for hematology values.
GraphPad Prism® v8 was used to calculate Pearson’s correlation
between TUNEL and CC3 cell count. Cytokine change from
baseline was calculated using Wilcoxon’s matched-pairs signed-
rank test. Using IBM SPSS® v22, physiological data and clinical
outcomes were analyzed using t test or Fisher’s exact test as
appropriate.
RESULTS
Baseline characteristics and physiological parameters
Piglet weight ranged from 1800 to 2250 g. Physiological
parameters are shown in Table 1. At baseline groups were similar.
During the time epochs 1–25 and 25–35 h, which encompass
cooling and rewarming, the HT subjects had lower core
temperatures as expected (p < 0.001 and 0.002, respectively).
HI insult
Insult severity, as determined by the duration of insult, MABP <
30, isoelectric EEG, area under the curve (AUC) FiO2, AUC oxCCO,
and end HI acid–base status, was similar between groups
(Table 2).
Survival and clinical illness severity
During active cooling, HT animals had a lower mean heart rate
than NT animals (171 (SD 25) b.p.m. compared with 235 (SD 21)
b.p.m., p= 0.001). Mean heart rate was also lower during
rewarming for HT animals (p= 0.02) (Table 1). Mean MABP,
inotropic support, and saline bolus requirement were not
different between groups (Table 3). Mean infusion rates of all
inotropes were higher in the HT group; however, confidence
intervals are wide. HT had higher mean blood glucose at 24 h
(10.3 (SD 3.6) mmol/L compared with 6.5 (SD 1.2) mmol/L, p=
0.033). Three of six NT and four of six HT subjects had
hyperkalemia necessitating treatment (p= 0.5).
Two of six piglets died prior to experiment completion in the HT
group, compared with none in the NT group (p= 0.23). The two
animals had refractory hypotension and worsening metabolic
acidosis at the time of cardiac arrest (30 and 33 h). Both were
rewarmed early due to the severity of hypotension (at 16 and 12.5
h). One had severe hyperkalemia (K+ > 9). Both had macroscopic
necrosis to abdominal solid organs including the liver, kidneys,
and bowel.
TUNEL
Mean whole-brain TUNEL-positive cell counts were similar
between the NT and HT groups (p= 0.97) (Fig. 2a). The regional
assessment was also similar between groups. There was a trend
towards greater histological cell death in the internal capsule for
the TH group (p= 0.064).
Cleaved caspase-3
HT reduced overall CC3 (Fig. 2b) compared with NT (p= 0.04). The
regional analysis demonstrates lower CC3 in the internal capsule,
Table 1. Physiological observations and blood gas results throughout
the experiment.
Normothermia Hypothermia
Mean (SD) Mean (SD)
Weight (g) 2008 (132) 2075 (161)
Rectal temp ( °C)
Baseline 37.9 (0.8) 37.6 (0.4)
4 h LPS 38.6 (0.3) 38.6 (0.3)
End of insult 38.1 (0.5) 38.1 (0.3)
1–25 h 38.4 (0.1) 34.0 (0.5)**
25–35 h 38.7 (0.1) 36.5 (1.3)**
35–48 h 38.4 (0.2) 38.2 (0.2)
Heart rate (b.p.m.)
Baseline 169.1 (26.0) 151.7 (11.9)
4 h LPS 192.9 (15.0) 185.0 (12.6)
End of insult 237.3 (15.8) 225.6 (12.9)
1–25 h 234.9 (20.5) 170.9 (24.8)**
25–35 h 210.0 (25.2) 180.0 (8.7)*
35–48 h 185.2 (21.7) 173.0 (13.1)
MABP (mmHg)
Baseline 51.1 (4.3) 52.1 (1.4)
4 h LPS 53.1 (3.7) 54.1 (5.8)
End of insult 47.3 (6.3) 43.7 (5.6)
1–25 h 45.7 (5.4) 42.7 (9.8)
25–35 h 55.0 (5.2) 42.8 (15.0)
35–48 h 49.5 (2.9) 54.8 (4.5)
pH
Baseline 7.48 (0.19) 7.57 (0.10)
4 h LPS 7.44 (0.10) 7.45 (0.07)
End of insult 7.22 (0.11) 7.25 (0.13)
12 h 7.49 (0.07) 7.44 (0.17)
24 h 7.47 (0.03) 7.38 (0.13)
48 h 7.47 (0.04) 7.48 (0.05)
PaCO2 (kPa)
Baseline 6.3 (3.4) 4.3 (0.8)
4 h LPS 5.8 (1.0) 5.6 (0.7)
End of insult 6.3 (1.8) 5.6 (0.9)
12 h 5.3 (0.6) 4.4 (1.1)
24 h 5.4 (0.7) 5.1 (1.3)
48 h 5.2 (0.6) 5.0 (0.4)
PaO2 (kPa)
Baseline 18.6 (2.7) 15.0 (4.3)
4 h LPS 10.4 (1.1) 10.8 (0.9)
End of insult 3.6 (0.4) 3.7 (0.9)
12 h 13.7 (4.8) 15.5 (6.6)
24 h 12.8 (3.1) 10.7 (4.0)
48 h 15.2 (3.9) 14.6 (1.8)
BE (mmol/L)
Baseline 8.5 (3.3) 7.7 (4.4)
4 h LPS 5.9 (3.4) 5.1 (3.4)
End of insult −9.0 (2.9) −8.7 (4.9)
12 h 6.8 (3.4) −0.3 (10.5)
24 h 5.7 (2.1) −1.7 (9.8)
48 h 4.5 (2.4) 5.4 (4.9)
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caudate nucleus, and hippocampus (p= 0.006, 0.01, and 0.02,
respectively). There was no correlation between TUNEL-positive
cell count and CC3-positive cell count (r=−0.42, 95% CI −0.54 to
−0.30).
Glial fibrillary acidic protein
Mean whole-brain and regional GFAP luminosity was similar
between the NT and HT groups (p= 0.89) (Fig. 2b).
Ionized calcium-binding adaptor molecule 1
IBA1-positive cell count was no different between the NT and HT
group throughout the whole brain (p= 0.41) and in each brain
region (p ≥ 0.08) (Fig. 2b). Overall microglial activation state
(ramification index) was also similar between groups (p= 0.81).
There was an increase in microglial activation (lower ramification
index) in the caudate nucleus with HT (p= 0.029). Microglia for
both groups appeared partially activated, with enlarged cell
bodies, a reduced number of processes, and thickening of the
remaining processes.
Representative photomicrographs from the internal capsule
area at ×40 magnification for all histological stains are shown in
Fig. 2c.
Amplitude-integrated electroencephalogram
All subjects had a normal (score 4) aEEG at baseline (Fig. 3). The
mean aEEG score for both groups was suppressed following HI
and remained suppressed throughout the experiment. There was
no effect of HT on aEEG recovery. Two of the six NT and one of the
six HT piglets had electrographic seizures (p= 0.5). Seizure onset
was at 12 and 15 h post HI for the two NT piglets, and at 36 h for
the one HT piglet with seizures. Seizure burden was no different
between groups (range 0–47min) (p= 0.75). Three of the six NT
and one of the six HT piglets were treated with phenobarbitone.
Phenobarbitone use and dose per kg were not different between
groups (p ≥ 0.34).
Magnetic resonance spectroscopy
Lac/NAA was no different between the cooled and normothermic
piglets at either time point, in either the white matter or thalamus
(Fig. 4, p ≥ 0.35 for all comparisons). Note that due to early death,
two of six HT subjects were not scanned at 48 h. Compared to all
others, these two deceased piglets had the highest thalamic Lac/
NAA at 24 h.
Hematology
In both groups, platelet count fell below baseline by time 0 (p ≤
0.024) (Fig. 5). NT platelet count returned to baseline levels,
before a late thrombocytosis at 48 h post HI (p < 0.001). HT
platelet count continued to fall below baseline for the duration
of cooling therapy (p ≤ 0.007), before a later recovery to baseline
at 48 h. At 24 and 48 h after HI, platelet count was suppressed in
the HT group compared with NT (p= 0.005 and 0.001,
respectively).
The WBC increased from baseline for NT subjects at 3, 12, and
24 h (p ≤ 0.016) (Fig. 5). This increase was attenuated in HT
subjects. There was no significant difference between WBC for NT
and HT animals at any single time point. Neutrophils were the
predominant leukocyte present and the analysis closely mirrored
that for WBC. There was no effect of cooling or time on
lymphocyte number. The monocyte count was raised at 24 h in
the HT group compared to baseline (p= 0.002). Monocytes were
otherwise unaltered by HT or time.
Table 1. continued
Normothermia Hypothermia
Mean (SD) Mean (SD)
Lactate (mmol/L)
Baseline 3.6 (1.7) 2.9 (1.2)
4 h LPS 4.1 (2.0) 3.4 (1.3)
End of insult 13.1 (1.7) 11.0 (2.2)
12 h 3.0 (0.6) 6.6 (5.0)
24 h 2.3 (0.8) 6.7 (7.1)
48 h 1.1 (0.2) 1.3 (0.3)
Glucose (mmol/L)
Baseline 4.9 (1.3) 5.2 (1.2)
4 h LPS 6.0 (2.2) 5.6 (0.5)
End of insult 8.9 (3.0) 7.9 (1.0)
12 h 6.8 (1.2) 11.5 (5.6)
24 h 6.5 (1.2) 10.3 (3.6)*
48 h 4.5 (1.2) 4.9 (0.7)
Potassium (mmol/L)
Baseline 4.1 (0.7) 4.5 (0.4)
4 h LPS 4.5 (0.4) 5.0 (0.4)
End of insult 4.5 (0.5) 5.2 (0.8)
12 h 6.3 (0.7) 6.3 (1.0)
24 h 6.7 (0.7) 6.7 (1.4)
48 h 5.7 (1.2) 6.2 (1.3)
MABP mean arterial blood pressure, BE base excess.
*P < 0.05, **P < 0.005.
Table 2. HI insult severity measures.
Normothermia Hypothermia
Mean (SD) Mean (SD)
Duration HI (min) 20.7 (1.4) 21.2 (2.1)
AUC FiO2 (%) 295.8 (20.1) 290.5 (43.2)
Duration of EEG < 5 μV (min) 15.5 (2.9) 17.7 (1.8)
Duration of MABP < 30 (min) 7.3 (2.9) 10.0 (3.8)
AUC oxCCO 146 (25) 124 (50)
End of HI arterial gas
pH 7.22 (0.11) 7.25 (0.13)
pCO2 (kPa) 6.3 (1.8) 5.6 (0.9)
pO2 (kPa) 3.6 (0.4) 3.7 (0.9)
Base excess −9.0 (2.9) −8.7 (4.9)
Lactate (mmol/L) 13.1 (1.7) 11.0 (2.2)
No comparisons were p < 0.05
HI hypoxia–ischemia, EEG electroencephalogram, MABP mean arterial
blood pressure, oxCCO oxidized cytochrome c oxidase.
Table 3. Inotrope and saline bolus use throughout the experiment.
Normothermia Hypothermia
Mean (SD) Mean (SD)
Dopamine (μg/kg/min) 10.1 (4.8) 15.6 (6.4)
Dobutamine (μg/kg/min) 2.8 (4.5) 4.5 (6.9)
Noradrenaline (ng/kg/min) 16 (37) 96 (149)
Adrenaline (ng/kg/min) 0 (0) 484 (811)
10ml/kg Saline bolus (n) 0.7 (0.8) 0.8 (1.3)
No comparisons were p < 0.05.
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Fig. 2 Brain histology. a TUNEL histology. There was no difference between whole-brain or regional estimated least-squares mean (LSM) TUNEL-
positive cells per mm2. b LSM whole-brain and regional cleaved caspase-3 (CC3), GFAP, IBA1-positive cell count, and IBA1 ramification index.
Hypothermia reduced CC3 throughout the brain and in the internal capsule, caudate nucleus, and hippocampus. Hypothermia did not alter
astrogliosis. Cooling had no effect on the overall microglial number or activation state. There was an increase in microglial activation (lower
ramification index) in the caudate with HT. c Representative sections for each stain (TUNEL, CC3, GFAP, and IBA1) from the internal capsule are shown
at ×40 magnification. cCTX cingulate cortex, sCTX sensorimotor cortex, HIP hippocampus, PvWM periventricular white matter, IC internal capsule,
CAUD caudate, PTMN putamen, THAL thalamus. Data are displayed as analyzed, on a log 10 scale. Error bars represent 95% CI. *p < 0.05, **p < 0.01.
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There was no intergroup difference for Hb at any time point. NT
Hb was stable and then fell below baseline from 24 h (p= 0.002).
Hb increased from baseline in the HT group at 4 h after LPS and at
3 and 12 h after HI (p ≤ 0.012) (Fig. 5). At 48 h, both HT and NT Hb
were below baseline (p ≤ 0.022).
Cytokines
The pattern of IL-6, IL-8, and TNFα in the plasma and CSF is shown
in Fig. 6. Plasma IL-6, IL-8, and TNFα increased from baseline pre-HI
(p ≤ 0.0034) in response to LPS. HT plasma IL-6 was higher than NT
at 3 h post HI (p= 0.018). There were no other differences
between groups and no difference in CSF cytokines. IL-1β and IL-
10 were below the limit of detection for the majority of samples
and therefore were not analyzed.
DISCUSSION
In this piglet model of IS-HI, we did not observe protection with
24 h HT (from 1 to 25 h after HI) based on pre-defined primary
outcome measures; aEEG, MRS, and histological cell death (TUNEL-
positive cells). Microglial activation and glial cell proliferation were
unaltered, although microglial activation was increased in the
caudate nucleus with HT. Compared to NT, HT suppressed the
platelet and white cell count response. Plasma and CSF cytokine
response to LPS and HI was largely unchanged with HT. HT
reduced CC3 throughout the brain; in our model, CC3 is a poor
marker of cell death,30 and in this and previous studies, a regional
reduction in CC3 is associated with increased TUNEL-positive cells.
These results differ from non-sensitized HI piglet models, where
HT for 24 h started at 2 h after HI reduced brain injury based on
TUNEL-positive cell counts17 and HT for 12–24 h started immedi-
ately after HI ameliorated secondary energy failure, reduced
seizure activity, and improved neurological function and histo-
pathology scores.31,32 In the present study, a trend towards
increased TUNEL-positive cell death in the internal capsule with
HT was observed. Concurring with the histological data, aEEG and
1H MRS were not improved by HT. Comparing NT and HT groups,
there was no difference in aEEG score or seizure burden. The
mean aEEG score for HT trended upwards from 31 h; this may be
attributed to the loss of two subjects who had flat traces (score 0).
In NE babies, a recovery of aEEG within 48 h is associated with a
good outcome.33 1H MRS Lac/NAA peak area ratios in the white
matter and thalamus were not improved by HT. In non-sensitized
piglet models, HT for 24 h improves MRS biomarkers, including
Lac/NAA31,34,35 which is a robust marker of 2-year neurodevelop-
mental outcome in NE babies.36
Suppression of microglial activity is a favorable marker7 and a
key mechanism by which HT is neuroprotective.37,38 Reduced
microglial activation following HT is observed in non-sensitized
HI models, including the pig,17 sheep,38 and rodent.39 In this IS-
HI model, microglial number and morphology were not
suppressed by HT; indeed, in the caudate nucleus, microglial
morphology was indicative of a pro-inflammatory activation
state with HT, possibly reflecting increased injury. Our findings
concur with those from a rodent LPS-sensitized HI cooling
model.40 The balance between activated microglia with a pro-
inflammatory phenotype and those with an anti-inflammatory
restorative phenotype is complex and needs further study.7,12,41
Astrogliosis, measured by GFAP, was not impacted by HT. In
non-sensitized HI models, HT reduces astroglial activation.39 LPS
enhances astrogliosis by stimulating the release of TNFα, IL-1α,
and IL-6, mediators of astrocyte proliferation and activation.42,43
A failure of HT to suppress astrogliosis has also been shown in
an LPS-sensitized rodent model.40
CC3 was reduced by HT, both overall and specifically in the
internal capsule, caudate nucleus, and hippocampus. As in our
previous LPS+ hypoxia study10 and other recent piglet neuro-
protection studies,44,45 CC3 was not associated with TUNEL-
positive cell death. The use of male piglets may partly explain

























aEEG pattern classification score
3 4
0–6 h
LPS + HI + hypothermia LPS + HI + normothermia
7–12 h 13–18 h 19–24 h 25–30 h 31–36 h 37–42 h 43–48 h
Fig. 3 aEEG. Mean aEEG pattern classification score from baseline (BL) till 48 h, divided into 6 h time epochs (a) (±95% CI). There was no
difference between NT and HT aEEG scores at any time. The two crosses represent the deaths of two HT piglets at 30 and 33 h. Examples of
each pattern classification score are shown (b), where 0= flat trace, 1= low voltage, 2= burst suppression, 3= discontinuous normal voltage,
and 4= continuous normal voltage.
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death pathways are predominantly caspase-independent.46–48 We
may then conclude that CC3 is, therefore, a poor marker of cell
death in this model. LPS is known to increase CC3 without
resulting in apoptotic cell death.10,49 This CC3 response to LPS
likely reflects the immunologic functions of caspases, including
microglial and lymphocyte function, cell differentiation, and
autophagy.50 Of note, the largest reduction in CC3 with HT was
observed in the internal capsule, the same region where there was
a trend towards an increase in TUNEL-positive cell death.
HI, HT, and LPS each influence the hematological response.
Infection/inflammation triggers thrombocytopenia and leucocy-
tosis in neonates51 and piglets.10 HI also stimulates leucocyto-
sis.10,52 HT is known to reduce circulating platelets and WBC. A
meta-analysis of HT clinical trials demonstrated an increase in
thrombocytopenia (relative risk (RR) 1.21 (95% CI 1.05–1.40) with
HT, and an increase in leukopenia with whole-body HT (RR 5.7
(95% CI 1.02–31.82)).1 Similarly, in this study, HT suppressed both
platelet and leukocyte (neutrophil) count. The impact of this
suppression is uncertain in the setting of IS-HI. In a mouse model
of LPS-sensitized HI, neutrophils were central to injury pathways,
leading to leukocyte infiltration, pro-inflammatory cytokine
production, and brain atrophy.53 By contrast, an increase in
circulating neutrophils, and later lymphocytes, are necessary
components of the innate and adaptive immune response to
infectious stimuli. Leukopenic “immune paralysis” has been
demonstrated in neonates undergoing HT and was associated
with poorer outcome.16 Thus, alterations in immune cell
number may be an important factor in the efficacy and safety of
TH in IS-HI.
Many immune cells are functionally heat-sensitive54 and a key
mechanism of HT neuroprotection is inhibition of the pro-
inflammatory cascade.18,55,56 In a cohort of babies with NE, HT
infants had reduced serum IL-6 and IL-4, and increased vascular
endothelial growth factor (VEGF) compared with NT infants.57 In
the same cohort, there was a negative correlation between the
duration of cooling prior to sampling, and levels of IL-6, IL-10,
TNFα, and interferon-gamma (IFNγ).57 In another cohort, HT
lowered IL-6, and increased IL-10 at 48 h.58 Conversely, in a phase
II cooling trial, cooled infants had a biphasic pattern of elevated IL-
6, IL-8, IL-10, and chemokine (C-C motif) ligand 2 in comparison
with NT infants18 although another prospective cohort showed
serial cytokine values (IL-1, IL-6, IL-8, TNFα, IFNγ, and VEGF) were
unaffected by HT.59 In our study, plasma and CSF cytokine profiles
were not influenced by HT. IL-6, IL-8, and TNFα increased from
baseline in response to LPS. IL-6 was higher at 3 h post HI in HT
compared to NT. The inability of HT to suppress pro-inflammatory
cytokine production in IS-HI may contribute to the lack of cooling
effect. Indeed, in one cooling cohort, neonates that failed to
downmodulate pro-inflammatory cytokines in response to HT had
poorer outcome.18
Mortality in HT was 33% (two deaths), compared with no deaths
in NT. Neonates with both infection/inflammation and an
intrapartum hypoxic event are at increased risk of mortality; in a
large meta-analysis of cooled and non-cooled infants, mortality
amongst infants with both group B Streptococcus sepsis and NE
was higher than for infants with NE alone (RR 2.07 (95% CI
1.47–2.91)).13 In our previous normothermic piglet study, the











































































































Fig. 4 MRS. There is no effect of hypothermia on the ratio of lactate to N-acetylaspartate (Lac/NAA) in the thalamus or white matter at 24 or
48 h after HI. In all subjects, log 10 Lac/NAA data points are shown in the graphs on the left/center, and are summarized using log 10 least-
squares (LS) means plot with 95% CI error bars in the boxes on the right. The crosses indicate the two HT piglets who died prior to the 48 h
scan.
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hypoxia alone.10 In this study, the two cardiac arrests were
preceded by refractory hypotension, which may have been
contributed to by HT-induced bradycardia. Indeed, in a meta-
analysis of cooling trials, HT increased sinus bradycardia, although
there was no increase in hypotension or major arrhythmias.1 The
HT group was hyperglycemic during the cooling phase. HT
reduces insulin secretion and increases insulin resistance in
preclinical models and adult HT studies.60 Deranged postnatal
glycemic control is an important risk factor for the adverse
outcome as seen in the Coolcap study61 and is associated with
specific patterns of brain injury in NE.62 Two piglets in the HT
group had macroscopic abdominal organ necrosis, including the
bowel, at post mortem.
There are limitations to this study. By using E. coli LPS to
stimulate inflammation, we modeled only gram-negative perinatal
infection. Rodent models of IS-HI, comparing LPS with PAM3CSK4
(a toll-like receptor (TLR) 2 agonist, which simulates gram-positive
infection), demonstrate the differences in temperature, cytokine
expression, CC3, and glial cell response.40 Importantly, the efficacy
of HT was pathogen-dependent; HT was neuroprotective with
PAM3CSK4 IS-HI, but not with LPS IS-HI.14,15,25 Two of six piglets in
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Fig. 5 Hematology. Least-squares mean values over time for platelets, white blood cells (WBC), neutrophils, lymphocytes, monocyte counts,
and hemoglobin (±SEM). Pale blue shading represents cooling. *P < 0.05, **p < 0.01, and ***p < 0.0001 for change from baseline value, with
color denoting group; #p < 0.05 for the difference at timepoint between the NT and HT group.
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consistent with clinical practice. These two piglets died prema-
turely, reducing the available outcome data at later time points.
With reduced numbers, the study may have been underpowered
to demonstrate differences in later outcome measures, including
aEEG and MRS. Histological outcomes measures were available for
all 12 subjects, including the two piglets that died prematurely.
Only male piglets were used to reduce intergroup variation. We
were therefore not able to examine the impact of sex on
outcome.46 Future studies using this model of IS-HI will be
conducted using both male and female piglets. The porcine
immune system is an ideal model for immunology research,
resembling humans by >80%. However, there are differences, for
example, piglets are born without transplacental antibodies
in contrast to human neonates.63 This impacts interpretation of
the immunomodulatory effects of HT. The insult in this study was
a combined carotid artery occlusion with hypoxia rather than a
pure hypoxia model where we observed significant systemic
injury.10
HT was undertaken for 24 h (from 1 to 25 h) in the present
study, a duration that is protective in our non-sensitized piglet HI
model (when HT commencement was delayed to 2 h)17 and allows
time for gradual rewarming and subsequent neuroimaging under
normothermic conditions within the timeframe of our established
48 h model.64,65 HT maintained for ≤24 h is neuroprotective in
rodent and porcine models of non-sensitized HI.17,31,32 The closer
to HI that HT is commenced in these models, the greater the
neuroprotection and the shorter the duration of cooling
required.37 However, optimal cooling duration, based on pre-
clinical66,67 and clinical studies,68 is 72 h. In the fetal lamb, 72 h HT
(from 3 to 75 h) provided maximal neuroprotection following HI
compared with either 48 or 120 h HT, with regards to EEG and
histological outcome measures,66,69 with the rate of rewarming of
lesser importance.70 Thus, we cannot exclude the possibility of a
different effect of 72 versus 24 h cooling in IS-HI.
In this IS-HI model, both LPS and HI stimulate systemic multi-
organ inflammatory responses and injury. Plasma cytokines were
1–2 orders of magnitude higher than CSF cytokines, suggesting
predominant peripheral immune cell response in this model. HT
effects on the peripheral immune response may have impacted
upon brain injury. Whole-body cooling was undertaken in this
study, consistent with clinical care. Selective head cooling may
have a differential effect on whole-body cooling, through
avoidance of systemic HT immunomodulation.
Our results, suggesting no protection with HT in IS-HI, may be
related to (i) failure of HT to inhibit microglial activation,
astrogliosis, and inflammatory cytokine production; (ii) attenuation
of neutrophil numbers by HT; (iii) secondary brain injury from
hemodynamic instability; and (iv) abnormal glycemic control.
Following HI, HT inhibits both protective and damaging cellular
pathways; in IS-HI, the balance of inhibition may be detrimental.
Given the dual role of the immune response in both contributing
to and preventing injury, and the complex mechanisms under-
pinning the evolution of HI injury, therapies targeting immuno-
modulation, rather than inflammation suppression, require
exploration.7,71
Novel neuroprotective therapies require exploration in IS-HI
models. In experimental rodent models of IS-HI, promising
therapies include melatonin,72 N-acetylcysteine,73 hydrocorti-
sone,74 and inflammatory cascade inhibitors/antagonists of IL-1
receptor,75 nuclear factor kappa beta,76 plasminogen activator
protein-1,77 and histone deacetylase.78 Other possible therapies
include erythropoietin,79,80 mesenchymal stem cells (MSCs),81 TLR
modulators,71,82 cyclooxygenase-2 inhibitors,83 and immunomo-
dulatory antibiotics such as azithromycin84 and minocycline.85 It
will be important to assess therapies with and without HT; of
concern is the negated benefit, or even exacerbation of injury,
observed with therapies such as IL-1 receptor antagonists86 and
MSCs87 when combined with HT.
Unlike the protection seen previously with 24 h HT (from 2 to
26 h) in the piglet HI model,17 we did not observe protection with
24 h HT (from 1 to 25 h) in a model of IS-HI. Our observation was
based on EEG, MRS, and TUNEL-positive cell death. The reduced
efficacy of HT, in the context of IS-HI, may relate to the inability of
HT to alter glial cell function and pro-inflammatory cytokine
profile as well as systemic effects of hyperglycemia and
hemodynamic instability. Hypothermic suppression of leukocytes,
platelets, and CC3 may be detrimental to systemic inflammatory
illness. Novel neuroprotective agents with immunomodulatory
properties require exploration in IS-HI models.
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